Radial Extracorporeal Shockwave Therapy (rESWT) for Coccydynia: a Quasi-experimental Case Series
Launched by BARTS & THE LONDON NHS TRUST · Mar 1, 2023
Trial Information
Current as of May 22, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18 years
- • VAS pain level ≥6
- • Diagnosis of coccydynia (persistent pain in the coccygeal area consistent with coccydynia)
- Exclusion Criteria:
- • Age \<18 years
- • Local or systemic neurological disease
- • Rheumatological disease
- • Malignant disease
- • Previous spinal surgery or spinal disease
- • Coagulopathies
- • Pregnancy
- • VAS pain level \<6
- • Recent (≤6 weeks) trauma to the coccyx
About Barts & The London Nhs Trust
Barts and The London NHS Trust is a leading healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality clinical care, research, and education. As a prominent sponsor of clinical trials, the Trust is dedicated to advancing medical knowledge and improving patient outcomes through innovative research initiatives. With a focus on patient safety and ethical standards, Barts and The London NHS Trust collaborates with multidisciplinary teams to explore cutting-edge therapies and interventions across various medical fields, ensuring that trial participants receive the highest level of care and support throughout their involvement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials